CD Biosynsis offers expert Gene Knockout Services for Pseudomonas putida, leveraging advanced genome editing technologies such as CRISPR/Cas9 and homologous recombination. As a robust host for biomanufacturing and degradation, P. putida requires precise genetic modification to optimize metabolic pathways, eliminate side-product formation, and enhance tolerance to harsh conditions. Our comprehensive services ensure high-efficiency, scarless gene deletions (single or multiplex), providing researchers and industries with rationally engineered strains for enhanced chemical production and bioremediation applications.
Get a QuotePseudomonas putida is gaining prominence as a versatile microbial chassis due to its high respiratory capacity, intrinsic robustness, and broad substrate utilization range. However, inherent metabolic pathways can divert carbon flux away from target products. Our Gene Knockout Service is designed to precisely "rewire" the cell's metabolism. By deleting unwanted genes (e.g., those responsible for competing pathways or protease production), we can effectively redirect carbon flow, increase product yield, and stabilize the engineered strain for industrial fermentation processes. This capability is essential for successful metabolic engineering projects.
CRISPR/Cas9 Delivery
Utilizing inducible expression systems or specialized plasmid vectors for efficient delivery of Cas9 and guide RNAs (gRNAs) into P. putida strains.
Targeted Double-Strand Breaks (DSBs)
Precise targeting of the gene of interest, facilitating the subsequent repair via homologous recombination with a donor template for scarless deletion.
Multiplex Knockouts
Simultaneous deletion of multiple genes in a single step to rapidly optimize complex metabolic pathways.
Suicide Vectors
Construction of suicide plasmids carrying upstream and downstream homology arms flanking the target gene.
Two-Step Recombination
Executing insertion and excision steps, often utilizing counter-selection markers (e.g., sacB) for efficient removal of the selection cassette and plasmid backbone.
Marker-Free Deletion
Final engineered strains are free of antibiotic resistance genes or non-native genetic "scars," making them suitable for regulatory purposes and industrial scale-up.
Non-Polar Mutations
Careful design to ensure the deletion does not disrupt the expression of downstream genes within the same operon.
Our service provides an efficient, validated, and quality-controlled process for generating engineered P. putida strains.
1. Design & Synthesis
2. Construction & Transformation
3. Selection & Screening
4. Validation & Delivery
Target gene identification and sequence retrieval.
Design of Cas9 gRNAs and homology arms/donor templates.
Synthesis of necessary DNA fragments and construction of delivery plasmids.
Electroporation or conjugation to introduce the gene editing components (e.g., CRISPR plasmids) into the target P. putida strain.
Optimized conditions for high transformation efficiency.
Genotype Validation: Sequencing the modified locus to confirm scarless and precise gene deletion.
Phenotype Verification: Growth curve and basic titer measurement (optional).
Deliver the verified, pure knockout strain and a comprehensive final report.
Metabolic Flux Redirection
Deleting competing pathways (e.g., pathways consuming key intermediate metabolites) to maximize the flux toward the desired product.
Enhanced Bioremediation
Removing genes that hinder the complete degradation of target pollutants or deleting regulatory genes to enhance degradation rates.
Improving Strain Stability
Knockout of genes involved in protease production, phage integration, or non-essential mobile genetic elements to improve product purity and strain robustness.
Developing Auxotrophs
Generating strains requiring specific nutrients for containment and safety purposes, or for simplifying selection during subsequent genetic rounds.
High-Efficiency Scarless Deletion
Our optimized protocols ensure the precise, marker-free removal of target genes, resulting in stable, industrial-ready strains.
Expertise in P. putida Chassis
Deep knowledge of P. putida specific genetics, delivery systems (e.g., conjugation), and counter-selection markers.
Multiplex Editing Capability
Ability to perform rapid, simultaneous deletion of up to five genes in one cycle, significantly accelerating strain optimization time.
What is the difference between single and multiplex knockout?
Single knockout deletes one gene at a time. Multiplex knockout, typically using CRISPR systems, allows for the simultaneous deletion of multiple target genes in a single strain engineering cycle, drastically speeding up pathway optimization.
Why is scarless gene deletion important for industrial strains?
Scarless deletion means no non-native DNA (such as antibiotic resistance genes or residual plasmid sequences) remains in the final host. This is crucial for meeting regulatory standards and preventing potential strain instability or unintended metabolic load in large-scale fermentation.
What kind of validation data do you provide?
We provide full DNA sequencing of the modified genomic locus to confirm the exact deletion. We also provide the final engineered strain in a pure culture and a detailed report documenting the process and verification results.
Can you perform gene replacement (knock-in) as well as knockout?
Yes. Our advanced gene editing platform is fully capable of performing gene replacement (inserting a new gene or modifying an existing sequence) using a similar homologous recombination strategy guided by CRISPR/Cas9.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.